UBS Cuts Price Target on Clorox (CLX) to $111 Following 1Q EPS Miss

November 3, 2016 8:50 AM EDT
Get Alerts CLX Hot Sheet
Price: $121.27 +0.22%

Rating Summary:
    3 Buy, 16 Hold, 4 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 18 | Down: 17 | New: 10
Trade CLX Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

UBS maintained a Sell rating on Clorox (NYSE: CLX), and cut the price target to $111.00 (from $118.00), following the company's 1Q earnings report. CLX missed EPS, reporting $1.36 compared to consensus of $1.42. CLX lowered FY17 EPS guidance to $5.23-$5.43 (from $5.38-$5.58 prior).

Analyst Stephen Powers commented, "For the second consecutive quarter, CLX missed EPS (delivering Q1:17 EPS of $1.36 vs. UBSe/cons. of $1.41/$1.42). Revenues grew +4.0% (vs. UBSe/cons. of +3.2%/+2.8%) and +6.0% FX-neutral (vs. UBSe +5.5%) on strong volumes (+8.0%) and help from M&A (a ~+2.0% contribution from Renew Life)—however, weaker gross margins (-61 bps vs. of UBSe +20 bps) and higher taxes (32.2% vs. UBSe of 30.5%) weighed on results. Additionally, CLX lowered FY17 EPS guidance to $5.23-$5.43 (from $5.38-$5.58 prior) as it now expects a lower tax benefit (~$0.15) from the adoption of ASU 2016-09, although it maintained underlying FY17 EPS guidance of $5.13-$5.28."

For an analyst ratings summary and ratings history on Clorox click here. For more ratings news on Clorox click here.

Shares of Clorox closed at $115.67 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

UBS, Earnings

Add Your Comment